Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations.
作者信息
Li Ming, Zhan Cheng
机构信息
Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
出版信息
Ann Transl Med. 2019 Sep;7(Suppl 6):S199. doi: 10.21037/atm.2019.07.22.
Abstract
摘要
相似文献
1
Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations.
Ann Transl Med. 2019 Sep;7(Suppl 6):S199. doi: 10.21037/atm.2019.07.22.
2
Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial Essay.
J Thorac Oncol. 2018 Jun;13(6):855-862. doi: 10.1016/j.jtho.2018.02.023. Epub 2018 Mar 6.
3
Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
AJR Am J Roentgenol. 2013 Dec;201(6):W812-20. doi: 10.2214/AJR.12.10169.
4
Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.
Lung Cancer. 2015 Jul;89(1):50-6. doi: 10.1016/j.lungcan.2015.04.014. Epub 2015 May 4.
5
Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer.
Transl Lung Cancer Res. 2019 Feb;8(1):58-69. doi: 10.21037/tlcr.2018.10.07.
6
Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches.
Lung Cancer. 2018 Sep;123:142-148. doi: 10.1016/j.lungcan.2018.07.002. Epub 2018 Jul 4.
7
Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
J Urol. 2019 Jun;201(6):1097-1104. doi: 10.1097/JU.0000000000000111.
8
Stereotactic ablative body radiotherapy for lung cancer.
Clin Oncol (R Coll Radiol). 2015 May;27(5):280-9. doi: 10.1016/j.clon.2015.01.006. Epub 2015 Mar 4.
9
Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Radiat Oncol. 2018 Apr 2;13(1):57. doi: 10.1186/s13014-018-1001-6.
10
Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
Surg Oncol Clin N Am. 2016 Jul;25(3):553-66. doi: 10.1016/j.soc.2016.02.008.
引用本文的文献
1
Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I-IIIA non-small cell lung cancer: a propensity-matched analysis.
J Thorac Dis. 2020 Jun;12(6):3043-3056. doi: 10.21037/jtd-20-898.
本文引用的文献
1
Troubleshooting in advanced VATS procedures.
Ann Transl Med. 2019 Jun;7(11):248. doi: 10.21037/atm.2019.05.39.
2
Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.
Clin Lung Cancer. 2019 Sep;20(5):370-377.e3. doi: 10.1016/j.cllc.2019.04.001. Epub 2019 Apr 25.
3
Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma.
Cell. 2019 Jun 13;177(7):1842-1857.e21. doi: 10.1016/j.cell.2019.05.013. Epub 2019 May 30.
4
Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions: A Systematic Review.
J Thorac Oncol. 2019 Aug;14(8):1332-1342. doi: 10.1016/j.jtho.2019.04.018. Epub 2019 May 7.
5
Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
Lung Cancer. 2019 Feb;128:127-133. doi: 10.1016/j.lungcan.2018.12.022. Epub 2018 Dec 24.
6
Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches.
Lung Cancer. 2018 Sep;123:142-148. doi: 10.1016/j.lungcan.2018.07.002. Epub 2018 Jul 4.
7
Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database.
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818783904. doi: 10.1177/1533033818783904.
8
Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):186-194. doi: 10.1016/j.ijrobp.2018.01.064. Epub 2018 Feb 3.
9
Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives.
Lung Cancer (Auckl). 2018 Mar 16;9:13-23. doi: 10.2147/LCTT.S129833. eCollection 2018.
10
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222.
Zotero 插件